Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last A$31.50 AUD
Change Today -0.37 / -1.16%
Volume 327.1K
As of 1:10 AM 10/13/15 All times are local (Market data is delayed by at least 15 minutes).

sirtex medical ltd (SRX) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/13/15 - A$39.95
52 Week Low
03/17/15 - A$14.80
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SIRTEX MEDICAL LTD (SRX)

Related News

No related news articles were found.

sirtex medical ltd (SRX) Related Businessweek News

No Related Businessweek News Found

sirtex medical ltd (SRX) Details

Sirtex Medical Limited, a life-sciences company, develops and distributes oncology treatments using small particle technology in the Asia Pacific, North and South America, Europe, the Middle East, and Africa. It primarily provides SIR-Spheres Y-90 resin microspheres, a medical device used in interventional oncology to deliver selective internal radiation therapy to the liver. The company is based in North Sydney, Australia.

246 Employees
Last Reported Date: 08/12/15

sirtex medical ltd (SRX) Top Compensated Officers

Chief Executive Officer, Managing Director an...
Total Annual Compensation: A$1.2M
Chief Financial Officer and Company Secretary
Total Annual Compensation: A$542.9K
Global Head of Operations
Total Annual Compensation: A$507.1K
Chief Executive Officer of Europe
Total Annual Compensation: A$627.4K
Chief Executive Officer of Asia Pacific Regio...
Total Annual Compensation: A$602.6K
Compensation as of Fiscal Year 2015.

sirtex medical ltd (SRX) Key Developments

Sirtex Medical Limited Appoints Katherine Woodthorpe as Independent Non-Executive Director

Sirtex Medical Limited announced the appointment of Dr. Katherine Woodthorpe as an Independent Non-Executive Director of the company, effective from September 22, 2015. Dr. Woodthorpe is an experienced Non-Executive Director, serving on boards ranging from ASX listed companies to research institutions and government entities for over 17 years. Dr. Woodthorpe was the Chief Executive of AVCAL, the Australian Private Equity and Venture Capital Association for seven years.

Sirtex Medical Limited Reports Audited Consolidated Earnings Results for the Year Ended June 30, 2015

Sirtex Medical Limited reported audited consolidated earnings results for the year ended June 30, 2015. For the period, the company reported revenue from the sale of goods was $176,088,000 compared to $129,363,000 a year ago. Profit before tax was $52,768,000 compared to $31,110,000 a year ago. Profit for the year was $40,345,000 compared to $23,868,000 a year ago. Diluted earnings per share were 69.7 cents compared to 41.3 cents a year ago. Net cash provided by operating activities was $51,974,000 compared to $32,171,000 a year ago. Purchase of plant and equipment was $1,692,000 compared to $6,189,000 a year ago. Net Tangible asset backing per ordinary security was 135.5 cents compared to 107.3 cents a year ago. EBITDA was $32,702,000 against $55,147,000 a year ago. The effective tax rate increased 20 basis points to 23.5% in 2015.

Sirtex Medical Limited Declares Final Fully Franked Dividend, Payable on October 21, 2015

Sirtex Medical Limited declared a final fully franked dividend of 20.0 cents per share for the 2015 financial year, an increase of 6.0 cents or 42.9% over the prior corresponding period. The record date for the dividend is 30th September 2015 and the payment date is 21st October 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SRX:AU A$31.50 AUD -0.37

SRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AngioDynamics Inc $12.33 USD +0.10
BTG PLC 567.00 GBp +7.00
Delcath Systems Inc $0.56 USD -0.01
Merit Medical Systems Inc $23.89 USD +0.04
View Industry Companies

Industry Analysis


Industry Average

Valuation SRX Industry Range
Price/Earnings 43.5x
Price/Sales 9.7x
Price/Book 11.9x
Price/Cash Flow 42.5x
TEV/Sales 9.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SIRTEX MEDICAL LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at